JP2007531766A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531766A5
JP2007531766A5 JP2007506547A JP2007506547A JP2007531766A5 JP 2007531766 A5 JP2007531766 A5 JP 2007531766A5 JP 2007506547 A JP2007506547 A JP 2007506547A JP 2007506547 A JP2007506547 A JP 2007506547A JP 2007531766 A5 JP2007531766 A5 JP 2007531766A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
formula
cyclohexane
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506547A
Other languages
English (en)
Japanese (ja)
Other versions
JP4954864B2 (ja
JP2007531766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/010878 external-priority patent/WO2005113011A2/en
Publication of JP2007531766A publication Critical patent/JP2007531766A/ja
Publication of JP2007531766A5 publication Critical patent/JP2007531766A5/ja
Application granted granted Critical
Publication of JP4954864B2 publication Critical patent/JP4954864B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506547A 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用 Expired - Fee Related JP4954864B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55940504P 2004-04-01 2004-04-01
US60/559,405 2004-04-01
US58699204P 2004-07-08 2004-07-08
US60/586,992 2004-07-08
PCT/US2005/010878 WO2005113011A2 (en) 2004-04-01 2005-03-31 Prodrugs of ion channel modulating compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2007531766A JP2007531766A (ja) 2007-11-08
JP2007531766A5 true JP2007531766A5 (enExample) 2008-04-24
JP4954864B2 JP4954864B2 (ja) 2012-06-20

Family

ID=34972985

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007506547A Expired - Fee Related JP4954864B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用
JP2007506319A Expired - Fee Related JP4991037B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2007506319A Expired - Fee Related JP4991037B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物

Country Status (6)

Country Link
US (2) US7786119B2 (enExample)
EP (1) EP1729814A2 (enExample)
JP (4) JP4954864B2 (enExample)
CA (1) CA2561733A1 (enExample)
MX (1) MXPA06011420A (enExample)
WO (1) WO2005094897A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041841A1 (en) * 2003-05-02 2009-02-12 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
EP1729815A2 (en) 2004-04-01 2006-12-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
WO2005097087A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
JP4954864B2 (ja) * 2004-04-01 2012-06-20 カーディオム ファーマ コーポレイション イオンチャネル調節化合物のプロドラッグおよびその使用
US8692002B2 (en) * 2004-11-18 2014-04-08 Cardiome Pharma Corp. Synthetic process for aminocyclohexyl ether compounds
MX2007016248A (es) 2005-06-15 2008-03-07 Cardiome Pharma Corp Procedimiento sintetico para la preparacion de compuestos de eter aminociclohexilico.
JP5004067B2 (ja) * 2005-10-31 2012-08-22 東レ・ファインケミカル株式会社 ベンジルオキシ含窒素環状化合物の製造法
JP2007131597A (ja) * 2005-11-11 2007-05-31 Toray Fine Chemicals Co Ltd ベンジルオキシピロリジン誘導体の製造方法
JP5004073B2 (ja) * 2006-06-13 2012-08-22 東レ・ファインケミカル株式会社 光学活性ベンジルオキシピロリジン誘導体塩酸塩粉体及びその製造法
WO2007052578A1 (ja) * 2005-10-31 2007-05-10 Toray Fine Chemicals Co., Ltd. ベンジルオキシピロリジン誘導体の製造方法および光学活性ベンジルオキシピロリジン誘導体塩酸塩粉体の製造法
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
WO2009032286A2 (en) 2007-09-06 2009-03-12 Nektar Therapeutics Al, Corporation Oligomer-calcium channel blocker conjugates
US20110009446A1 (en) * 2008-01-11 2011-01-13 Nektar Therapeutics Oligomer-guanidine class conjugates
BRPI0919920A2 (pt) * 2008-10-22 2016-02-16 Acucela Inc compostos para tratamento de doenças e desordens oftálmicas
EP2413694A4 (en) * 2009-04-03 2014-02-26 Univ Toledo PEG-ALBUMIN COMPOSITION WITH AT LEAST ONE PROTECTED THIOL REGION AS MEDICAMENTAL PLATFORM
US8993614B2 (en) 2012-03-15 2015-03-31 F. Hoffmann-La Roche Ag Substituted pyrrolidine-2-carboxamides
US9974759B2 (en) 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684728A (en) * 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
IT1145362B (it) 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
US5160734A (en) * 1987-11-25 1992-11-03 American Cyanamid Company Sustained release delivery system for substituted dihydropyridine calcium channel blockers
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US5219564A (en) 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US20030186869A1 (en) 1990-05-14 2003-10-02 George Poiani Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US6517824B1 (en) 1990-05-14 2003-02-11 University Of Medicine & Denistry Of New Jersey Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US5244889A (en) 1991-11-26 1993-09-14 Ciba-Geigy Corporation Certain macrocyclic lactam derivatives
US6217869B1 (en) 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5298492A (en) 1992-08-04 1994-03-29 Schering Corporation Diamino acid derivatives as antihypertensives
US6191105B1 (en) 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
CA2140553A1 (en) 1993-06-11 1994-12-22 Hitoshi Oinuma Amino acid derivative
EP0720605B1 (en) * 1993-09-24 2001-12-19 University Of British Columbia Aminocyclohexylesters and uses thereof
KR20040068613A (ko) 1994-03-25 2004-07-31 이소테크니카 인코포레이티드 중수소화된 화합물 이를 포함하는 고혈압 치료용 조성물
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
SI0932399T1 (sl) * 1996-03-12 2006-10-31 Pg Txl Co Lp Vodotopna paklitakselna predzdravila
US6214966B1 (en) 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
AU5194998A (en) 1996-11-01 1998-05-29 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and uses therefor
EP0884325A1 (en) 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
US6342507B1 (en) 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
DE69840586D1 (de) 1997-10-08 2009-04-02 Isotechnika Inc Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
EE04548B1 (et) * 1998-04-01 2005-10-17 Nortran Pharmaceuticals Inc. Aminotskloheksleeterhendid, nende kompositsioonid ja nende kasutamine
AU4551199A (en) 1998-06-08 1999-12-30 Advanced Medicine, Inc. Novel therapeutic agents for membrane transporters
CA2346656A1 (en) * 1998-10-20 2000-04-27 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
WO2000047547A2 (en) * 1999-02-12 2000-08-17 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
KR20020008167A (ko) 1999-04-29 2002-01-29 플레믹 크리스티안 잠재적 항정신병제로서의 글리신 분해계 저해제
CA2311483A1 (en) * 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
WO2002028412A1 (en) 2000-10-05 2002-04-11 Zealand Pharmaceuticals A/S Novel use of peptide
JP2004509949A (ja) * 2000-09-26 2004-04-02 ザ ユニバーシティ オブ アリゾナ ファウンデーション 化合物および癌またはウイルス性感染症治療におけるその使用方法
JP2002105067A (ja) 2000-09-28 2002-04-10 Teijin Ltd 2−フェニルチアゾール誘導体、およびそれを有効成分とする医薬組成物
US7057053B2 (en) * 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) * 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US6631745B2 (en) 2001-07-02 2003-10-14 Fmc Technologies, Inc. Riser pull-in method and apparatus
US6623729B2 (en) 2001-07-09 2003-09-23 Korea Advanced Institute Of Science And Technology Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
US20030026764A1 (en) 2001-07-31 2003-02-06 Immunomedics, Inc. Polymeric delivery systems
JP2003113084A (ja) 2001-10-02 2003-04-18 Mitsubishi Pharma Corp 肺高血圧症の治療及び/または予防薬
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
TW200407310A (en) 2002-06-07 2004-05-16 Glaxo Group Ltd Compounds
NZ537770A (en) * 2002-06-21 2007-03-30 Suven Life Sciences Ltd Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
CN1678326A (zh) * 2002-06-28 2005-10-05 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
WO2004014973A2 (en) * 2002-08-13 2004-02-19 Sirus Pharmaceuticals Ltd Biodegradable polymer
WO2004082585A2 (en) 2003-03-20 2004-09-30 Sirus Pharmaceuticals Ltd Water-soluble conjugates of phenytoin
SI1560812T1 (sl) * 2003-05-02 2006-10-31 Cardiome Pharma Corp Aminocikloheksil etrske spojine in njihove uporabe
CA2524034A1 (en) * 2003-05-02 2004-11-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
KR100495009B1 (ko) 2003-07-02 2005-06-14 삼성전자주식회사 화상형성 장치의 전사벨트 텐션 자동 인가 장치
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
WO2005079861A2 (en) 2004-02-13 2005-09-01 Safeway Investments Ltd. Polymeric water soluble prodrugs
JP4954864B2 (ja) * 2004-04-01 2012-06-20 カーディオム ファーマ コーポレイション イオンチャネル調節化合物のプロドラッグおよびその使用
EP1729815A2 (en) 2004-04-01 2006-12-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
WO2005097203A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Serum protein conjugates of ion channel modulating compounds and uses thereof
MX2007016248A (es) * 2005-06-15 2008-03-07 Cardiome Pharma Corp Procedimiento sintetico para la preparacion de compuestos de eter aminociclohexilico.
US7845611B1 (en) * 2007-11-16 2010-12-07 Sholander Alfred M Door operated page turner device, system and method for books

Similar Documents

Publication Publication Date Title
JP2007531766A5 (enExample)
JP5632910B2 (ja) C型肝炎ウイルス阻害剤
RU2399620C2 (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
JP2002509908A5 (enExample)
JP2006524222A5 (enExample)
RU2000127720A (ru) Аминоциклогексилово-эфирные соединения и их применение
KR20220154174A (ko) Yap/taz-tead 단백질-단백질 상호작용 억제제로서의 바이아릴 유도체
CA2326777A1 (en) Aminocyclohexyl ether compounds and uses thereof
JP7759877B2 (ja) 治療用化合物
EP4479387A1 (en) Inhibitors of parg
TWI693220B (zh) 1,3,4-噻二唑化合物及其用於治療癌症之用途
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2015516420A5 (enExample)
RU2010154172A (ru) Соединения для лечения рака
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
HRP20140687T1 (hr) Derivati benzofurana
MXPA03005777A (es) Derivados de triazol diaminas sustituidos como inhibidores de cinasa.
JP2007531731A5 (enExample)
RU2009120229A (ru) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
JP2010513434A5 (enExample)
JP2008539267A5 (enExample)
JP2020511547A5 (enExample)
JP2008525400A5 (enExample)
JP2013514974A5 (enExample)
JP2020516616A5 (enExample)